JAMA Current Issue

Revising US MMR Vaccine Recommendations Amid Changing Domestic Risks

This Viewpoint discusses updating the existing recommendation for an additional early MMR dose to infants aged 6 to 11 months traveling to any region with increased probability of measles exposure.

Apr 8, 2025 - 16:45
 0
This Viewpoint discusses updating the existing recommendation for an additional early MMR dose to infants aged 6 to 11 months traveling to any region with increased probability of measles exposure.
Read More

Tags:

Previous Article

Fireflies

Next Article

High-Intensity vs Low-Intensity NPPV and Need for Endotracheal Intubation

Related Posts

Using Machine Learning to Reassess Clinical Guidelines

Mar 18, 2025  0

Molecular Phenotyping With Proteomics

Mar 11, 2025  0

Study: Travel Time Is a Metric for Emergency Care Access

Mar 25, 2025  0